Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
YZG-331
AOB16587
CAS: N/A
Chemical Name: N6-[(S)-1-(Phenyl)-propyl]-adenosine; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-[6-[[(1S)-1-phenylpropyl]amino]purin-9-yl]oxolane-3,4-diol
1000 Items
Overview
Novel inhbitor of spontaneous locomotor activity, exerting sedative and hypnotic effects through A1R and A2aR
Chemical Properties
| Molecular Formula | C19H23N5O4 |
| Molecular Weight | 385.42 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| IUPAC/Chemical Name | N6-[(S)-1-(Phenyl)-propyl]-adenosine; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-[6-[[(1S)-1-phenylpropyl]amino]purin-9-yl]oxolane-3,4-diol |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
Synonyms
YZG331; YZG 331